133 related articles for article (PubMed ID: 10629022)
1. Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates.
Bonfiglio G; Cascone C; Azzarelli C; Cafiso V; Marchetti F; Stefani S
J Antimicrob Chemother; 2000 Jan; 45(1):115-7. PubMed ID: 10629022
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients.
Di Bonaventura G; D'Antonio D; Catamo G; D'Ercole S; Piccolomini R
Chemotherapy; 2002 Jul; 48(3):134-7. PubMed ID: 12138329
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates.
Chung HS; Hong SG; Kim YR; Shin KS; Whang DH; Ahn JY; Park YJ; Uh Y; Chang CL; Shin JH; Lee HS; Lee K; Chong Y
J Korean Med Sci; 2013 Jan; 28(1):62-6. PubMed ID: 23341713
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from a Korean tertiary care hospital.
Chung HS; Hong SG; Lee Y; Kim M; Yong D; Jeong SH; Lee K; Chong Y
Yonsei Med J; 2012 Mar; 53(2):439-41. PubMed ID: 22318836
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?
Galles AC; Jones RN; Sader HS
J Chemother; 2008 Feb; 20(1):38-42. PubMed ID: 18343741
[TBL] [Abstract][Full Text] [Related]
6. Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections.
Passerini de Rossi B; García C; Calenda M; Vay C; Franco M
Int J Antimicrob Agents; 2009 Sep; 34(3):260-4. PubMed ID: 19362452
[TBL] [Abstract][Full Text] [Related]
7. In vitro synergistic/additive activity of levofloxacin with meropenem against Stenotrophomonas maltophilia.
Pankey GA; Ashcraft DS
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):297-300. PubMed ID: 20542209
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Wei C; Ni W; Cai X; Zhao J; Cui J
PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activities of gatifloxacin against nosocomial isolates of Stenotrophomonas maltophilia measured by MIC and time-kill studies.
Cohn ML; Waites KB
Antimicrob Agents Chemother; 2001 Jul; 45(7):2126-8. PubMed ID: 11408235
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones.
Graves A; Henry M; O'Brien TP; Hwang DG; Van Buskirk A; Trousdale MD
Cornea; 2001 Apr; 20(3):301-5. PubMed ID: 11322420
[TBL] [Abstract][Full Text] [Related]
11. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.
Jia W; Wang J; Xu H; Li G
Int J Environ Res Public Health; 2015 May; 12(5):5177-95. PubMed ID: 25985315
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
Baltch AL; Smith RP; Ritz W
Antimicrob Agents Chemother; 1995 Aug; 39(8):1661-6. PubMed ID: 7486896
[TBL] [Abstract][Full Text] [Related]
13. The bactericidal activity of levofloxacin against ampicillin-resistant and ampicillin-susceptible Haemophilus influenzae in comparison with ofloxacin, ciprofloxacin and sparfloxacin.
Dabernat H
Int J Antimicrob Agents; 1999 Feb; 11(2):139-43. PubMed ID: 10221417
[TBL] [Abstract][Full Text] [Related]
14. Levofloxacin and ciprofloxacin in vitro activities against 4,003 clinical bacterial isolates collected in 24 Italian laboratories.
Gesu GP; Marchetti F; Piccoli L; Cavallero A
Antimicrob Agents Chemother; 2003 Feb; 47(2):816-9. PubMed ID: 12543701
[TBL] [Abstract][Full Text] [Related]
15. Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies.
Grillon A; Schramm F; Kleinberg M; Jehl F
PLoS One; 2016; 11(6):e0156690. PubMed ID: 27257956
[TBL] [Abstract][Full Text] [Related]
16. Comparison of in vitro susceptibilities to levofloxacin and ciprofloxacin with Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients in Northern Ireland.
McKnight AJ; Shaw A; Goldsmith CE; Clarke L; Millar BC; McCaughan J; Elborn JS; Reid A; Moore JE
Br J Biomed Sci; 2005; 62(1):30-2. PubMed ID: 15816210
[No Abstract] [Full Text] [Related]
17. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y
Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
[TBL] [Abstract][Full Text] [Related]
18. Activity of Delafloxacin and Levofloxacin against Stenotrophomonas maltophilia at Simulated Plasma and Intrapulmonary pH Values.
Vialichka A; Biagi M; Meyer K; Wu T; Shajee A; Tan X; Wenzler E
Microbiol Spectr; 2022 Aug; 10(4):e0270521. PubMed ID: 35862943
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of levofloxacin against gram-positive bacteria.
Montanari MP; Mingoia M; Marchetti F; Varaldo PE
Chemotherapy; 1999; 45(6):411-7. PubMed ID: 10567771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
